PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
EP1065207A1
(fr)
*
|
1999-07-02 |
2001-01-03 |
Aventis Pharma Deutschland GmbH |
Dérivées de la naphthyridine, procédés pour leur preparation, leur utilisation, et compositions pharmaceutique les contenant
|
DE19948417A1
(de)
*
|
1999-10-07 |
2001-04-19 |
Morphochem Ag |
Imidazol-Derivate und ihre Verwendung als Arzneimittel
|
EP1218360B1
(fr)
*
|
1999-10-07 |
2008-05-28 |
Amgen Inc., |
Inhibiteurs de triazine kinase
|
SI1235830T1
(en)
|
1999-12-10 |
2004-06-30 |
Pfizer Products Inc. |
PYRROLO(2,3-d)PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS
|
EP1782800B1
(fr)
*
|
2000-01-24 |
2013-12-18 |
Genzyme Corporation |
Procédés de détection d'inhibiteurs de JAK3
|
DE60129926T2
(de)
*
|
2000-01-24 |
2008-06-19 |
Genzyme Corp., Cambridge |
Inhibitoren des jak/stat-weges und deren verwendung zur behandlung von allgemeiner primärer osteoarthritis
|
MY137020A
(en)
*
|
2000-04-27 |
2008-12-31 |
Abbott Lab |
Diazabicyclic central nervous system active agents
|
JP4068958B2
(ja)
*
|
2000-06-26 |
2008-03-26 |
ファイザー・プロダクツ・インク |
免疫抑制剤としてのピロロ(2,3−d)ピリミジン化合物
|
US6864255B2
(en)
|
2001-04-11 |
2005-03-08 |
Amgen Inc. |
Substituted triazinyl amide derivatives and methods of use
|
US6881737B2
(en)
|
2001-04-11 |
2005-04-19 |
Amgen Inc. |
Substituted triazinyl acrylamide derivatives and methods of use
|
US7301023B2
(en)
*
|
2001-05-31 |
2007-11-27 |
Pfizer Inc. |
Chiral salt resolution
|
GB0115393D0
(en)
*
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
AP2003002929A0
(en)
*
|
2001-06-23 |
2003-12-31 |
Aventis Pharma Inc |
Pyrrolopyrimidines as protein kinase inhibitors
|
US7323469B2
(en)
|
2001-08-07 |
2008-01-29 |
Novartis Ag |
7H-pyrrolo[2,3-d]pyrimidine derivatives
|
GB0119249D0
(en)
|
2001-08-07 |
2001-10-03 |
Novartis Ag |
Organic compounds
|
GT200200234A
(es)
|
2001-12-06 |
2003-06-27 |
|
Compuestos cristalinos novedosos
|
US6642381B2
(en)
*
|
2001-12-27 |
2003-11-04 |
Hoffman-La Roche Inc. |
Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
|
PT1474425E
(pt)
|
2002-01-07 |
2006-09-29 |
Eisai Co Ltd |
Desazapurinas e sua utilizacao
|
GB0202679D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
EP1388541A1
(fr)
*
|
2002-08-09 |
2004-02-11 |
Centre National De La Recherche Scientifique (Cnrs) |
Pyrrolopyrazines utilisées comme inhibiteurs de kinases
|
WO2004047843A1
(fr)
|
2002-11-26 |
2004-06-10 |
Pfizer Products Inc. |
Methode de traitement d'un rejet de greffe
|
WO2004093812A2
(fr)
*
|
2003-04-22 |
2004-11-04 |
Irm Llc |
Composes induisant une differentiation neuronale dans des cellules souche embryonnaires
|
US7169918B2
(en)
*
|
2003-10-27 |
2007-01-30 |
Genelabs Technologies, Inc. |
Methods for preparing 7-(2′-substituted-β-D-ribofuranosyl)-4-(NR2R3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives
|
US20050239806A1
(en)
*
|
2004-01-13 |
2005-10-27 |
Ambit Biosciences Corporation |
Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
|
GB0403606D0
(en)
*
|
2004-02-18 |
2004-03-24 |
Novartis Ag |
Organic compounds
|
AU2005249380C1
(en)
*
|
2004-04-23 |
2012-09-20 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
US20110104186A1
(en)
|
2004-06-24 |
2011-05-05 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
JP2008505088A
(ja)
|
2004-06-29 |
2008-02-21 |
アムゲン インコーポレイティッド |
ACK1およびLCK活性を調節するピロロ[2,3−d]ピリミジン
|
WO2006017443A2
(fr)
|
2004-08-02 |
2006-02-16 |
Osi Pharmaceuticals, Inc. |
Composes a base de pyrrolopyrimidine a substitution arylamine inhibiteurs de kinases multiples
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
FR2880626B1
(fr)
*
|
2005-01-13 |
2008-04-18 |
Aventis Pharma Sa |
Derives de la purine, compositions les contenant et utilisation
|
US7423043B2
(en)
|
2005-02-18 |
2008-09-09 |
Lexicon Pharmaceuticals, Inc. |
4-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds
|
US8183248B2
(en)
|
2005-05-13 |
2012-05-22 |
Irm Llc |
Substituted pyrrolo[2,3-d]pyrimidines and compositions as protein kinase inhibitors
|
CN102127078A
(zh)
|
2005-07-14 |
2011-07-20 |
安斯泰来制药株式会社 |
Janus激酶3的杂环类抑制剂
|
CA2615291A1
(fr)
|
2005-07-14 |
2007-01-18 |
Astellas Pharma Inc. |
Inibiteurs heterocycliques de la janus kinase 3
|
EP2270014A1
(fr)
|
2005-09-22 |
2011-01-05 |
Incyte Corporation |
Inhibiteurs de l'azépine de janus kinases
|
SG151327A1
(en)
*
|
2005-09-30 |
2009-04-30 |
Vertex Pharmaceuticals Incopor |
Deazapurines useful as inhibitors of janus kinases
|
EP3466953B1
(fr)
|
2005-12-13 |
2021-02-03 |
Incyte Holdings Corporation |
Dérivé de pyrrolo[2,3-b]pyrimidine en tant qu'inhibiteur de janus kinase
|
AU2015201850B2
(en)
*
|
2005-12-13 |
2017-03-02 |
Incyte Holdings Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
|
EA200801968A1
(ru)
*
|
2006-03-11 |
2009-02-27 |
Вернэлис (Р&Д) Лтд. |
Пирролопиримидиновые производные, используемые в качестве ингибиторов hsp90
|
AU2007235487A1
(en)
*
|
2006-04-05 |
2007-10-18 |
Vertex Pharmaceuticals Incorporated |
Deazapurines useful as inhibitors of janus kinases
|
GB0608176D0
(en)
*
|
2006-04-25 |
2006-06-07 |
Astex Therapeutics Ltd |
Pharmaceutical Compounds
|
EP2043655A2
(fr)
|
2006-04-25 |
2009-04-08 |
Astex Therapeutics Limited |
Derives de purine et de deazapurine comme composes pharmaceutiques
|
WO2008012635A2
(fr)
*
|
2006-07-26 |
2008-01-31 |
Pfizer Products Inc. |
Dérivés d'amines utiles en tant qu'agents anticancéreux
|
US20080221132A1
(en)
*
|
2006-09-11 |
2008-09-11 |
Xiong Cai |
Multi-Functional Small Molecules as Anti-Proliferative Agents
|
US20080161320A1
(en)
*
|
2006-09-11 |
2008-07-03 |
Xiong Cai |
Fused bicyclic pyrimidines as ptk inhibitors containing a zinc binding moiety
|
AR064416A1
(es)
*
|
2006-12-21 |
2009-04-01 |
Cancer Rec Tech Ltd |
Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
|
WO2008075007A1
(fr)
*
|
2006-12-21 |
2008-06-26 |
Cancer Research Technology Limited |
Composé bicyclohétéroarylés substitué par morpholino et leur utilisation en tant qu'agents anti-cancer
|
CA2673038C
(fr)
|
2006-12-22 |
2015-12-15 |
Incyte Corporation |
Composes heteroaryls tricycliques substitues comme inhibiteurs de kinase janus
|
CN101578285A
(zh)
|
2007-01-12 |
2009-11-11 |
安斯泰来制药株式会社 |
稠合吡啶化合物
|
CN101679440A
(zh)
*
|
2007-04-02 |
2010-03-24 |
帕劳制药股份有限公司 |
作为jak3抑制剂的吡咯并嘧啶衍生物
|
UA99284C2
(ru)
|
2007-05-11 |
2012-08-10 |
Елі Ліллі Енд Компані |
ИНГИБИТОРЫ р70 S6-КИНАЗЫ
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
SI2173752T2
(sl)
|
2007-06-13 |
2022-09-30 |
Incyte Holdings Corporation |
Soli inhibitorja za janus kinazo (r)-3-(4-(7h-pirolo(2,3-d)pirimidin-4- il)-1h-pirazol-1-il)-3-ciklopentilpropannitrila
|
GB0713602D0
(en)
*
|
2007-07-12 |
2007-08-22 |
Syngenta Participations Ag |
Chemical compounds
|
WO2009016132A1
(fr)
*
|
2007-07-27 |
2009-02-05 |
Janssen Pharmaceutica Nv |
Pyrrolopyrimidines
|
EP2597098A1
(fr)
|
2007-08-08 |
2013-05-29 |
Lexicon Pharmaceuticals, Inc. |
(7h-pyrrolo [2, 3-d] pyrimidin-4-yl) -pipérazines en tant qu'inhibiteurs de kinase pour le traitement du cancer et l'inflammation
|
WO2009030871A1
(fr)
*
|
2007-09-07 |
2009-03-12 |
Vernalis R & D Ltd |
Dérivés de pyrrolopyrimidine présentant une activité inhibitrice d'hsp90
|
CN101861321B
(zh)
|
2007-10-11 |
2013-02-06 |
阿斯利康(瑞典)有限公司 |
作为蛋白激酶b抑制剂的吡咯并[2,3-d]嘧啶衍生物
|
CN101910152B
(zh)
|
2007-11-16 |
2014-08-06 |
因塞特公司 |
作为janus激酶抑制剂的4-吡唑基-n-芳基嘧啶-2-胺和4-吡唑基-n-杂芳基嘧啶-2-胺
|
KR20120108042A
(ko)
|
2008-03-11 |
2012-10-04 |
인사이트 코포레이션 |
Jak 억제제로서의 아제티딘 및 시클로부탄 유도체
|
WO2009131940A1
(fr)
|
2008-04-21 |
2009-10-29 |
Lexicon Pharmaceuticals, Inc. |
Inhibiteurs de limk2, compositions les comprenant et leurs procédés d'utilisation
|
JP2011518836A
(ja)
|
2008-04-24 |
2011-06-30 |
インサイト・コーポレイション |
大環状化合物およびそれらのキナーゼ阻害剤としての使用
|
PL2384326T3
(pl)
|
2008-08-20 |
2014-09-30 |
Zoetis Services Llc |
Związki pirolo[2,3-d]pirymidyonowe
|
US8385364B2
(en)
*
|
2008-09-24 |
2013-02-26 |
Nec Laboratories America, Inc. |
Distributed message-passing based resource allocation in wireless systems
|
CL2009001884A1
(es)
*
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
JOP20190231A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
DE102009005193A1
(de)
*
|
2009-01-20 |
2010-07-22 |
Merck Patent Gmbh |
Neue heterocyclische Verbindungen als MetAP-2 Inhibitoren
|
WO2010085597A1
(fr)
|
2009-01-23 |
2010-07-29 |
Incyte Corporation |
Composés macrocycliques et leur utilisation en tant qu'inhibiteurs des kinases
|
EP2396004A4
(fr)
|
2009-02-11 |
2012-07-25 |
Reaction Biology Corp |
Inhibiteurs de kinase sélectifs
|
ES2552805T3
(es)
|
2009-04-20 |
2015-12-02 |
Auspex Pharmaceuticals, Llc |
Inhibidores piperidínicos de la cinasa Janus 3
|
MX2011012353A
(es)
*
|
2009-05-22 |
2011-12-14 |
Incyte Corp |
Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2, 3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de la cinasa janus.
|
AR076920A1
(es)
|
2009-05-22 |
2011-07-20 |
Incyte Corp |
3-(4-(7h-pirrolo(2,3-d)pirimidin-4-il)-1h-pirazol-1-il)octano-o heptano--nitrilo como inhibidores de jak
|
TW201105674A
(en)
|
2009-07-08 |
2011-02-16 |
Leo Pharma As |
Novel JAK receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof
|
TWI466885B
(zh)
*
|
2009-07-31 |
2015-01-01 |
Japan Tobacco Inc |
含氮螺環化合物及其醫藥用途
|
TW201111385A
(en)
*
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
AR078012A1
(es)
|
2009-09-01 |
2011-10-05 |
Incyte Corp |
Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus
|
AU2010289321A1
(en)
|
2009-09-04 |
2012-04-05 |
The Regents Of The University Of Michigan |
Compositions and methods for treatment of leukemia
|
ES2711936T3
(es)
|
2009-09-04 |
2019-05-08 |
Biogen Ma Inc |
Inhibidores de la tirosina cinasa de Bruton
|
CN105541847B
(zh)
|
2009-10-09 |
2019-08-16 |
因西特控股公司 |
3-(4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基)-3-环戊基丙腈的羟基衍生物、酮基衍生物和葡糖苷酸衍生物
|
CA2776028C
(fr)
|
2009-10-15 |
2015-12-01 |
Pfizer Inc. |
Composes pyrrolo[2,3-d]pyrimidine
|
US9074143B2
(en)
*
|
2009-12-11 |
2015-07-07 |
Uop Llc |
Process for producing hydrocarbon fuel
|
CA2782720A1
(fr)
|
2009-12-18 |
2011-06-23 |
Pfizer Inc. |
Composes pyrrolo[2,3-d]pyrimidines
|
AU2011213198B2
(en)
|
2010-02-05 |
2014-04-24 |
Zoetis Llc |
Pyrrolo [ 2,3-d] pyrimidine urea compounds as JAK inhibitors
|
MX2012009541A
(es)
*
|
2010-02-18 |
2012-10-01 |
Incyte Corp |
Derivados de ciclobutano y metilciclobutano como inhibidores de janus cinasa.
|
AR081315A1
(es)
|
2010-03-10 |
2012-08-08 |
Incyte Corp |
Derivados heterociclicos de piperidin y pirimidin -4-il-azetidina, una forma cristalina de la sal del acido acetonitriladipico de un derivado pirimidinico, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades relacionadas con la inhibicion de jak-1, t
|
CN103002875B
(zh)
|
2010-05-21 |
2016-05-04 |
因塞特控股公司 |
Jak抑制剂的局部用制剂
|
EP2590981B1
(fr)
|
2010-07-09 |
2014-09-03 |
Leo Pharma A/S |
Nouveaux dérivés d'homopipérazine comme inhibiteurs de protéines tyrosine kinases et leur utilisation pharmaceutique
|
CN102372717B
(zh)
*
|
2010-08-20 |
2014-06-18 |
和记黄埔医药(上海)有限公司 |
吡咯并嘧啶类化合物及其用途
|
RU2563644C2
(ru)
|
2010-08-20 |
2015-09-20 |
Хатчисон Медифарма Лимитед |
Пирролопиримидиновые соединения и их применения
|
WO2012022045A1
(fr)
*
|
2010-08-20 |
2012-02-23 |
Hutchison Medipharma Limited |
Composés pyrrolopyrimidiniques et leurs utilisations
|
TWI401258B
(zh)
*
|
2010-09-08 |
2013-07-11 |
Hutchison Medipharma Ltd |
吡咯並嘧啶類化合物及其用途
|
BR112013012502A2
(pt)
|
2010-11-19 |
2019-03-06 |
Incyte Corporation |
pirrolopiridina ciclobutil substituída e derivados de pirrolopirimidina derivativos como inibidores de jak
|
EP2640725B1
(fr)
|
2010-11-19 |
2015-01-07 |
Incyte Corporation |
Pyrrolopyridines et pyrrolopyrimidines à substitution hétérocyclique utilisées en tant qu'inhibiteurs des jak
|
US9045485B2
(en)
|
2010-12-16 |
2015-06-02 |
Convergence Pharmaceuticals Limited |
ASK 1 inhibiting pyrrolopyrimidine derivatives
|
WO2012088682A1
(fr)
*
|
2010-12-29 |
2012-07-05 |
Shanghai Fochon Pharmaceutical Co Ltd. |
Dérivés de la 2-(3-aminopipéridin-1-yle)-[1,2,4] triazolo [1,5-c] pyrimidine-5,7 (3h,6h)-dione en tant qu'inhibiteurs de la dipeptidylpeptidase iv(dpp-iv)
|
KR20140058402A
(ko)
*
|
2011-01-07 |
2014-05-14 |
레오 파마 에이/에스 |
단백질 티로신 키나제 억제제로서의 신규한 설파미드 피페라진 유도체 및 이의 약제학적 용도
|
DE102011008352A1
(de)
*
|
2011-01-12 |
2012-07-12 |
Merck Patent Gmbh |
5-([1,2,3]Triazol-4-yl)-7H-pyrrolo-[2,3-d]pyrimidinderivate
|
US9139590B2
(en)
|
2011-02-04 |
2015-09-22 |
Duquesne University Of The Holy Spirit |
Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
|
EP2675451B9
(fr)
|
2011-02-18 |
2017-07-26 |
Novartis Pharma AG |
Plurithérapie impliquant un inhibiteur de mtor et un inhibiteur de jak
|
CA2830882C
(fr)
|
2011-03-22 |
2021-03-16 |
Dinesh Barawkar |
Composes tricycliques substitues; compositions et applications medicinales correspondantes
|
PT2694056T
(pt)
|
2011-04-01 |
2019-11-20 |
Astrazeneca Ab |
Tratamento terapêutico
|
MX344479B
(es)
|
2011-06-20 |
2016-12-16 |
Incyte Holdings Corp |
Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de cinasa janus (jak).
|
CA2838738A1
(fr)
*
|
2011-06-29 |
2013-01-03 |
Merck Sharp & Dohme Corp. |
Nouvelles formes cristallines d'un inhibiteur de peptidase-iv
|
CA2841111A1
(fr)
*
|
2011-07-08 |
2013-01-17 |
Novartis Ag |
Nouveaux derives de pyrrolopyrimidine
|
WO2013023119A1
(fr)
|
2011-08-10 |
2013-02-14 |
Novartis Pharma Ag |
Polythérapie par jak p13k/mtor
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
KR102035361B1
(ko)
|
2011-11-30 |
2019-11-08 |
아스트라제네카 아베 |
암의 병용 치료
|
CN107898790B
(zh)
|
2011-11-30 |
2024-06-21 |
埃默里大学 |
用于治疗或预防逆转录病毒和其它病毒感染的抗病毒jak抑制剂
|
US8993756B2
(en)
|
2011-12-06 |
2015-03-31 |
Merck Sharp & Dohme Corp. |
Pyrrolopyrimidines as janus kinase inhibitors
|
AU2013204533B2
(en)
|
2012-04-17 |
2017-02-02 |
Astrazeneca Ab |
Crystalline forms
|
WO2013173720A1
(fr)
|
2012-05-18 |
2013-11-21 |
Incyte Corporation |
Dérivés de pyrrolopyridine et de pyrrolopyrimidine substitués par un pipéridinylcyclobutyle à titre d'inhibiteurs jak
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
ES2637245T3
(es)
*
|
2012-06-29 |
2017-10-11 |
Pfizer Inc. |
Nuevas 4-(amino sustituido)-7H-pirrolo[2,3-d]pirimidinas como inhibidores de LRRK2
|
ES2889757T3
(es)
|
2012-09-06 |
2022-01-13 |
Plexxikon Inc |
Compuestos y procedimientos para la modulación de quinasas e indicaciones para estos
|
WO2014045305A1
(fr)
|
2012-09-21 |
2014-03-27 |
Advinus Therapeutics Limited |
Composés tricycliques condensés substitués, compositions et applications médicales correspondantes
|
US20150284394A1
(en)
*
|
2012-10-26 |
2015-10-08 |
Hoffmann-La Roche Inc. |
Inhibitors of bruton's tyrosine kinase
|
CN102936251A
(zh)
*
|
2012-11-05 |
2013-02-20 |
上海毕得医药科技有限公司 |
一种吡咯并[2,3-d]嘧啶衍生物的制备方法
|
UA120834C2
(uk)
|
2012-11-15 |
2020-02-25 |
Інсайт Холдінгс Корпорейшн |
Лікарські форми руксолітинібу зі сповільненим вивільненням
|
LT2958921T
(lt)
|
2013-02-22 |
2017-11-27 |
Pfizer Inc. |
Pirolo[2, 3 -d]pirimidino dariniai, kaip janus kinazės (jak) inhibitoriai
|
RS58547B1
(sr)
|
2013-03-06 |
2019-05-31 |
Incyte Holdings Corp |
Postupci i intermedijeri za dobijanje inhibitora jak
|
WO2014139388A1
(fr)
*
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Nouveaux dérivés d'indole utiles en tant qu'agents antidiabétiques
|
MY195091A
(en)
|
2013-08-07 |
2023-01-10 |
Incyte Corp |
Sustained Release Dosage Forms for a JAK1 Inhibitor
|
RS56728B1
(sr)
*
|
2013-12-05 |
2018-03-30 |
Pfizer |
Pirolo[2,3-d]pirimidinil, pirolo[2,3-b]pirazinil i pirolo[2,3-d]piridinil akrilamidi
|
ES2663622T3
(es)
|
2013-12-17 |
2018-04-16 |
Pfizer Inc. |
Novedosas 1H-pirrolo[2,3-b]piridinas 3,4-disustituidas y 7H-pirrolo[2,3-c]piridacinas 4,5-disustituidas como inhibidores de LRRK2
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
JP6585158B2
(ja)
|
2014-08-12 |
2019-10-02 |
ファイザー・インク |
ヤヌスキナーゼの阻害に有用なピロロ[2,3−d]ピリミジン誘導体
|
USRE49687E1
(en)
|
2014-09-09 |
2023-10-10 |
The Regents Of The University Of Michigan |
Thienopyrimidine and thienopyridine compounds and methods of use thereof
|
CN105524067A
(zh)
*
|
2014-09-28 |
2016-04-27 |
江苏柯菲平医药股份有限公司 |
4-取代吡咯并[2,3-d]嘧啶化合物及其用途
|
CA2984183C
(fr)
|
2015-05-01 |
2021-11-09 |
Pfizer Inc. |
Pyrrolo [2,3-d] pyrimidinyl, pyrrolo[2,3-b] pyrazinyl, pyrrolo [2,3-b] pyridinyl acrylamides et leur epoxydes
|
EP3302057A4
(fr)
|
2015-06-04 |
2018-11-21 |
Kura Oncology, Inc. |
Méthodes et compositions d'inhibition de l'interaction de la ménine avec les protéines mll
|
AR104020A1
(es)
|
2015-06-04 |
2017-06-21 |
Kura Oncology Inc |
Métodos y composiciones para inhibir la interacción de menina con proteínas mill
|
CA2989989C
(fr)
*
|
2015-07-31 |
2021-07-20 |
Taiho Pharmaceutical Co., Ltd. |
Compose pyrrolo[2,3-d]pyrimidine ou un sel de celui-ci
|
KR101771219B1
(ko)
*
|
2015-08-21 |
2017-09-05 |
양지화학 주식회사 |
야누스 키나제 1 선택적 억제제 및 그 의약 용도
|
JP6873980B2
(ja)
|
2015-09-14 |
2021-05-19 |
ファイザー・インク |
LRRK2阻害薬としての新規のイミダゾ[4,5−c]キノリンおよびイミダゾ[4,5−c][1,5]ナフチリジン誘導体
|
US10045981B2
(en)
|
2015-11-24 |
2018-08-14 |
Jakpharm, Llc |
Selective kinase inhibitors
|
CN107098908B
(zh)
*
|
2016-02-23 |
2021-01-08 |
欣凯医药科技(上海)有限公司 |
一种吡咯并嘧啶类化合物的制备方法和应用
|
JP7000333B2
(ja)
|
2016-03-16 |
2022-02-10 |
クラ オンコロジー,インク. |
メニン-mllの架橋された二環式阻害剤及びその使用方法
|
JP6919977B2
(ja)
|
2016-03-16 |
2021-08-18 |
クラ オンコロジー,インク. |
メニン−mllの置換された阻害剤及びその使用方法
|
CN107513067A
(zh)
|
2016-06-16 |
2017-12-26 |
北京赛林泰医药技术有限公司 |
含有取代环戊基的吡咯并嘧啶化合物
|
CN107513069A
(zh)
|
2016-06-16 |
2017-12-26 |
正大天晴药业集团股份有限公司 |
手性吡咯并嘧啶化合物的制备方法
|
MX2019000884A
(es)
|
2016-07-21 |
2019-09-04 |
Biogen Ma Inc |
Formas de succinato y composiciones de inhibidores de la tirosina cinasa de bruton.
|
WO2018140648A1
(fr)
|
2017-01-25 |
2018-08-02 |
Eric Jon Jacobsen |
Inhibiteurs d'itk à base de pyrrolopyrimidine pour traiter l'inflammation et le cancer
|
RU2761626C2
(ru)
*
|
2017-02-03 |
2021-12-13 |
Лео Фарма А/С |
ПРОИЗВОДНЫЕ 5-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-5-АЗАСПИРО[2.5]ОКТАН-8-КАРБОНОВОЙ КИСЛОТЫ В КАЧЕСТВЕ НОВЫХ ИНГИБИТОРОВ JAK-КИНАЗЫ
|
WO2018175746A1
(fr)
|
2017-03-24 |
2018-09-27 |
Kura Oncology, Inc. |
Méthodes de traitement d'hémopathies malignes et du sarcome d'ewing
|
CN108794480A
(zh)
*
|
2017-04-28 |
2018-11-13 |
天津药物研究院有限公司 |
吡咯并嘧啶类化合物、其制备方法和用途
|
US11542248B2
(en)
|
2017-06-08 |
2023-01-03 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with MLL proteins
|
US11649251B2
(en)
|
2017-09-20 |
2023-05-16 |
Kura Oncology, Inc. |
Substituted inhibitors of menin-MLL and methods of use
|
WO2019090143A1
(fr)
|
2017-11-03 |
2019-05-09 |
Aclaris Therapeutics, Inc. |
Analogues de pyrrolo[2,3-b]pyrimidine-5-carboxylate de pyrazolyle et leurs procédés de préparation
|
SG11202002947TA
(en)
|
2017-11-03 |
2020-04-29 |
Aclaris Therapeutics Inc |
Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same
|
WO2019113487A1
(fr)
|
2017-12-08 |
2019-06-13 |
Incyte Corporation |
Polythérapie à faible dose pour le traitement de néoplasmes myéloprolifératifs
|
SG11202007164UA
(en)
|
2018-01-30 |
2020-08-28 |
Incyte Corp |
Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
|
KR20210018203A
(ko)
|
2018-03-30 |
2021-02-17 |
인사이트 코포레이션 |
Jak 억제제를 사용하는 화농성 한선염의 치료
|
JP2021534244A
(ja)
|
2018-08-10 |
2021-12-09 |
アクラリス セラピューティクス,インコーポレイテッド |
ピロロピリミジンitk阻害剤
|
GB201818750D0
(en)
*
|
2018-11-16 |
2019-01-02 |
Institute Of Cancer Res Royal Cancer Hospital |
Lox inhibitors
|
CN109394768B
(zh)
*
|
2018-12-10 |
2019-08-23 |
牡丹江医学院 |
一种治疗湿疹的药物及其制备方法
|
EP3946606A1
(fr)
|
2019-03-27 |
2022-02-09 |
Insilico Medicine IP Limited |
Inhibiteurs de jak bicycliques et leurs utilisations
|
US11420966B2
(en)
|
2019-05-02 |
2022-08-23 |
Aclaris Therapeutics, Inc. |
Substituted pyrrolopyridines as JAK inhibitors
|
US11434291B2
(en)
|
2019-05-14 |
2022-09-06 |
Provention Bio, Inc. |
Methods and compositions for preventing type 1 diabetes
|
MX2022006176A
(es)
|
2019-11-22 |
2022-08-17 |
Incyte Corp |
Terapia combinada que comprende un inhibidor de alk2 y un inhibidor de jak2.
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
MX2022015872A
(es)
|
2020-06-11 |
2023-05-16 |
Provention Bio Inc |
Metodos y composiciones para prevenir diabetes tipo 1.
|
WO2023055731A1
(fr)
*
|
2021-09-28 |
2023-04-06 |
Sanford Burnham Prebys Medical Discovery Institute |
Inhibiteurs de la sérine/thréonine protéine kinase stk3 ou stk4 et leurs utilisations
|